Adial Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01

Aug. 16, 2022 9:28 AM ETAdial Pharmaceuticals, Inc. (ADIL)By: Deepa Sarvaiya, SA News Editor
  • Adial Pharmaceuticals press release (NASDAQ:ADIL): Q2 GAAP EPS of -$0.16 beats by $0.01.
  • As of June 30,2022, cash and cash equivalents were $9.2 million as compared to $6.1 million as of December 31, 2021, which the Company believes provides sufficient runway to advance ongoing regulatory and partnering activities related to AD04, as well as advancement of its Purnovate platform.
  • Shares +5% PM.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.